Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of GnRH Agonist Administration on Decreasing VAS, Estradiol, and Anti Mullerian Hormone in Endometriosis Cyst Patients

NCT06525155 is registered in ClinicalTrials.gov with Rumah Sakit Pusat Angkatan Darat Gatot Soebroto as lead sponsor.

NCT NCT06525155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06525155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of GnRH Agonist Administration on Decreasing VAS, Estradiol, and Anti Mullerian Hormone in Endometriosis Cyst Patients
Lead sponsor
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Phase
Phase 3
Overall status
Recruiting
Start date
January 2, 2024
Completion date
February 28, 2025
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis